Overview:
A fixed-dose combination of Artemether 80 mg and Lumefantrine 480 mg, offering a potent antimalarial therapy. It is effective against multidrug-resistant strains of Plasmodium and provides rapid symptom relief with minimal recurrence.
Artemisinin Combination Therapy (ACT)
Treatment of uncomplicated malaria caused by Plasmodium falciparum
Multidrug-resistant malaria
Relapse prevention after initial treatment
Artemether rapidly reduces parasite biomass by forming free radicals that damage parasite membranes, while Lumefantrine inhibits heme detoxification, starving the parasite of nutrients.